SEC
|
Ward Shane
|
Sr VP and Chief Legal SO
|
|
-107
|
$7.63
|
-$816.41
|
|
SEC
|
Fair Richard A.
|
President and CEO
|
|
+5K
|
$4.00
|
+$20.00K
|
|
SEC
|
Foster Aaron E.
|
Sr VP, Head of Research
|
|
+1.9K
|
$1.49
|
+$2.90K
|
|
SEC
|
Smith Alan K.
|
EVP, Technical Operations
|
|
+2.4K
|
$1.47
|
+$3.58K
|
|
SEC
|
Williams Rosemary Y.
|
VP, Finance & PAO
|
|
+1.3K
|
$1.47
|
+$1.89K
|
|
SEC
|
Woodard Jr Joseph Paul
|
SVP Clinical & Medical Affairs
|
|
+2.2K
|
$0.82
|
+$1.77K
|
|
SEC
|
Fair Richard A.
|
President and CEO
|
|
+40K
|
$1.25
|
+$50.00K
|
|
SEC
|
Ward Shane
|
Sr. VP and General Counsel
|
|
+8K
|
$1.23
|
+$9.84K
|
|
SEC
|
Fair Richard A.
|
President and CEO
|
|
+20K
|
$0.99
|
+$19.80K
|
|
SEC
|
Naeve Gregory S.
|
Chief Business Officer
|
|
-1.6K
|
$0.95
|
-$1.52K
|
|
SEC
|
Ward Shane
|
Sr. VP and General Counsel
|
|
-1.1K
|
$2.09
|
-$2.23K
|
|
SEC
|
Grossman William
|
Sr. VP, Chief Medical Officer
|
|
-3.1K
|
$3.48
|
-$10.88K
|
|
SEC
|
Smith Alan K.
|
EVP, Technical Operations
|
|
+2.4K
|
$3.28
|
+$7.98K
|
|
SEC
|
Spencer David M.
|
Chief Technology Officer
|
|
+2.5K
|
$3.28
|
+$8.30K
|
|
SEC
|
Williams Rosemary Y.
|
Principal Accounting Officer
|
|
+1.3K
|
$3.28
|
+$4.21K
|
|
SEC
|
Naeve Gregory S.
|
Chief Business Officer
|
|
+1K
|
$3.33
|
+$3.46K
|
|
SEC
|
Stonehouse Jon P
|
N/A
|
|
+10K
|
$4.56
|
+$45.60K
|
|
SEC
|
Spencer David M.
|
Chief Technology Officer
|
|
-10K
|
$7.04
|
-$70.40K
|
|
SEC
|
Naeve Gregory S.
|
Chief Business Officer
|
|
-1.6K
|
$6.74
|
-$10.76K
|
|
SEC
|
Spencer David M.
|
Chief Technology Officer
|
|
-40K
|
$7.63
|
-$305.20K
|
|
SEC
|
Musso Alan A
|
CFO and Treasurer
|
|
-6.2K
|
$7.97
|
-$49.46K
|
|
SEC
|
BAKER JULIAN
|
N/A
|
|
-881K
|
$8.20
|
-$7.22M
|
|
SEC
|
Smith Alan K.
|
EVP, Technical Operations
|
|
-487
|
$9.40
|
-$4.58K
|
|
SEC
|
Moseley Ken
|
Sr. VP and General Counsel
|
|
+974
|
$9.79
|
+$9.54K
|
|
SEC
|
Musso Alan A
|
CFO and Treasurer
|
|
+1.2K
|
$9.79
|
+$11.44K
|
|
SEC
|
Smith Alan K.
|
EVP, Technical Operations
|
|
+974
|
$9.79
|
+$9.54K
|
|
SEC
|
Spencer David M.
|
Chief Scientific Officer
|
|
+974
|
$9.79
|
+$9.54K
|
|
SEC
|
Musso Alan A
|
CFO and Treasurer
|
|
-17K
|
$9.33
|
-$159.70K
|
|
SEC
|
Musso Alan A
|
CFO and Treasurer
|
|
+6.2K
|
$9.89
|
+$61.38K
|
|
SEC
|
Smith Alan K.
|
EVP, Technical Operations
|
|
-437
|
$11.85
|
-$5.18K
|
|
SEC
|
Moseley Ken
|
Sr. VP and General Counsel
|
|
-14K
|
$12.26
|
-$169.47K
|
|
SEC
|
Spencer David M.
|
Chief Scientific Officer
|
|
-10K
|
$11.54
|
-$115.40K
|
|
SEC
|
Musso Alan A
|
CFO and Treasurer
|
|
-6.3K
|
$12.24
|
-$77.25K
|
|
SEC
|
Baker Bros. Advisors (GP) LLC
|
N/A
|
|
+167K
|
$12.00
|
+$2.00M
|
|
SEC
|
Slawin Kevin M.
|
N/A
|
|
-30K
|
$12.54
|
-$376.20K
|
|
SEC
|
Slawin Kevin M.
|
Chief Technology Officer
|
|
-30K
|
$15.45
|
-$463.50K
|
|
SEC
|
Spencer David M.
|
Chief Scientific Officer
|
|
-5K
|
$20.00
|
-$100.00K
|
|
SEC
|
Moseley Annemarie
|
COO/EVP Clinical Development
|
|
-25K
|
$17.54
|
-$438.50K
|
|
SEC
|
Spencer David M.
|
Chief Scientific Officer
|
|
-5K
|
$17.52
|
-$87.60K
|
|
SEC
|
Musso Alan A
|
CFO and Treasurer
|
|
-29K
|
$19.51
|
-$571.64K
|
|
SEC
|
Moseley Ken
|
Sr. VP and General Counsel
|
|
-12K
|
$20.10
|
-$237.18K
|
|
SEC
|
Slawin Kevin M.
|
Chief Technology Officer
|
|
-23K
|
$20.12
|
-$471.13K
|
|
SEC
|
Spencer David M.
|
Chief Scientific Officer
|
|
-17K
|
$19.88
|
-$328.02K
|
|
SEC
|
Moseley Ken
|
Sr. VP and General Counsel
|
|
-2.2K
|
$20.01
|
-$44.02K
|
|
SEC
|
Slawin Kevin M.
|
Chief Technology Officer
|
|
-4.6K
|
$20.01
|
-$91.73K
|
|
SEC
|
Spencer David M.
|
Chief Scientific Officer
|
|
-2.5K
|
$20.01
|
-$50.03K
|
|
SEC
|
Slawin Kevin M.
|
Chief Technology Officer
|
|
-15K
|
$15.00
|
-$225.00K
|
|
SEC
|
Spencer David M.
|
Chief Scientific Officer
|
|
-10K
|
$15.00
|
-$150.00K
|
|
SEC
|
Moseley Annemarie
|
COO/EVP Clinical Development
|
|
-25K
|
$13.00
|
-$325.00K
|
|
SEC
|
Moseley Ken
|
Sr. VP and General Counsel
|
|
-15K
|
$13.00
|
-$195.00K
|
|
SEC
|
Slawin Kevin M.
|
Chief Technology Officer
|
|
-55K
|
$11.43
|
-$628.65K
|
|
SEC
|
Moseley Annemarie
|
COO/EVP Clinical Development
|
|
-35K
|
$19.07
|
-$667.45K
|
|
SEC
|
Spencer David M.
|
Chief Scientific Officer
|
|
-5K
|
$22.95
|
-$114.75K
|
|
SEC
|
Musso Alan A
|
CFO and Treasurer
|
|
-29K
|
$22.34
|
-$654.56K
|
|
SEC
|
Slawin Kevin M.
|
Chief Technology Officer
|
|
-24K
|
$20.65
|
-$495.60K
|
|
SEC
|
Spencer David M.
|
Chief Scientific Officer
|
|
-5K
|
$19.00
|
-$95.00K
|
|
SEC
|
Farrell Thomas J.
|
President and CEO
|
|
-2.5K
|
$16.78
|
-$41.95K
|
|
SEC
|
Farrell Thomas J.
|
President and CEO
|
|
-2.5K
|
$20.24
|
-$50.60K
|
|
SEC
|
Slawin Kevin M.
|
Chief Technology Officer
|
|
-6K
|
$20.00
|
-$120.00K
|
|
SEC
|
Moseley Annemarie
|
COO/EVP Clinical Development
|
|
-35K
|
$20.62
|
-$721.70K
|
|
SEC
|
Moseley Ken
|
Sr. VP and General Counsel
|
|
-15K
|
$20.62
|
-$309.30K
|
|
SEC
|
Spencer David M.
|
Chief Scientific Officer
|
|
-20K
|
$22.96
|
-$459.20K
|
|